We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info . X close

Vendor Neutral Archive (VNA) & PACS Market: Growth, Size, Share, and Trends

Report Code HIT 2128
Published in May, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Vendor Neutral Archive (VNA) & PACS Market by Product Type (Department, Multi-department, Multi-site), Modality (CT, MRI, X-ray, Ultrasound, Mammo, PET), Application (Cardio, Onco, Neuro), End User (Hospital, ASC, Diag Center) & Region - Global Forecast to 2030

Overview

The global vendor-neutral archive (VNA) & picture archiving and communication systems (PACS) market, valued at US$4.62 billion in 2024, stood at US$5.10 billion in 2025 and is projected to advance at a resilient CAGR of 9.2% from 2025 to 2030, culminating in a forecasted valuation of US$7.92 billion by the end of the period. The growth in the medical imaging sector is predominantly fueled by the escalating volume of imaging data and a stronger regulatory push for EHR implementation. Additionally, the ongoing transition towards value-based care is prompting increased investments in scalable and interoperable imaging solutions. Key technological advancements, such as cloud-based storage, AI, and analytics integration, are significantly driving the adoption of VNA and PACS; these innovations facilitate improved clinical workflows, enhance data accessibility, and ultimately lead to better patient care outcomes.

Vendor Neutral Archive (VNA) & PACS Market – Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Vendor Neutral Archive (VNA) & PACS Market

North America

North America offers significant growth potential, driven by the widespread adoption of advanced imaging technologies, the increasing digitalization of healthcare systems, and the rising demand for interoperable and scalable data management platforms.

Factors such as growing imaging volumes, the push for integrated healthcare IT systems, and the need for efficient image sharing across healthcare networks accelerate the adoption of VNA and PACS across the region.

Strategic partnerships, cloud-based solution launches, and multi-site VNA deployments are expected to create strong market opportunities for both established players and new entrants over the next five years.

The North American VNA & PACS market is projected to grow at a significant CAGR, supported by rising investments in enterprise imaging infrastructure.

The region’s strong healthcare IT infrastructure, high per capita health expenditure, and increased government efforts to promote interoperability and patient data security continue to fuel the demand for next-generation archiving and communication solutions.

Global Vendor Neutral Archive (VNA) & PACS Market Dynamics

DRIVER: Increasing investments in medical imaging technologies

Electronic health record (EHR) systems serve as centralized digital repositories that aggregate comprehensive patient data, from medical histories to diagnostic results, enhancing the accessibility and collaboration among healthcare providers. This integration streamlines clinical workflows, minimizes duplicative efforts, and empowers data-driven decision-making, thereby significantly optimizing patient outcomes. In the contemporary healthcare landscape, the implementation of EHRs is pivotal. As of 2021, about 96% of non-federal acute care hospitals and 78% of office-based physicians in the US had adopted certified EHR systems, underscoring their critical role in advancing healthcare delivery; this trend mirrors a global initiative to digitize health records, aimed at improving operational efficiency and care quality.

Furthermore, EHR integration promotes interoperability across various health information technology systems, facilitating the synthesis and analysis of data from multiple sources, including pharmacy systems, laboratory information systems, and public health registries. This interconnected framework helps deliver comprehensive patient care, allowing for real-time data exchange and collaboration among multidisciplinary teams. Additionally, integrated EHRs enhance public health efforts by providing crucial data for disease surveillance and population health research initiatives, showcasing their broader impact beyond individual patient encounters.

RESTRAINT: Increasing data security and privacy concerns

The escalating digitization of medical imaging data has intensified concerns regarding data security and patient privacy, serving as a significant barrier to the widespread adoption of VNA and PACS solutions. Given the sensitive nature of the data handled by healthcare organizations, these entities are increasingly targeted by cyber threats. As reported by the HIPAA Journal, the healthcare sector witnessed a staggering 725 large-scale data breaches in 2023, compromising over 133 million patient records; this statistic underscores a marked increase in vulnerability compared to previous years, highlighting the urgent need for enhanced data protection strategies. The financial ramifications of these breaches are considerable. The HIPAA Journal cites that the average cost of a healthcare data breach in 2023 reached nearly USD 11 million, surpassing the average for all other industries. These costs not only cover immediate remedial expenses but also extend to long-term effects, including regulatory penalties, legal expenditures, and damage to institutional reputation. To address these cybersecurity challenges, healthcare organizations must deploy comprehensive security measures. This includes implementing data encryption protocols, enforcing multi-factor authentication, and conducting regular security audits. Adherence to compliance frameworks such as the Health Insurance Portability and Accountability Act (HIPAA) is also essential for safeguarding sensitive health information and maintaining trust in healthcare data systems.

 

OPPORTUNITY: Increasing medical imaging procedures and large imaging data silos

The increasing volume of medical imaging procedures has led to a significant rise in the demand for VNA and PACS solutions. These advanced systems provide scalable and efficient methods for managing vast amounts of imaging data, enabling healthcare providers to centralize medical images and their associated metadata into a standardized format. This standardization is crucial as it dismantles existing data silos, facilitating seamless interoperability across various systems and departments within healthcare organizations. The advancement and integration of artificial intelligence (AI) and data analytics into VNA and PACS solutions have brought about a transformative shift in the healthcare landscape. These technologies allow for automated image analysis, enabling healthcare professionals to quickly identify patterns and anomalies in medical images with greater accuracy. Predictive analytics tools use historical data to forecast potential health issues, assisting clinicians in making proactive decisions about patient care. Furthermore, clinical decision support systems leverage AI to provide evidence-based recommendations to healthcare providers, thereby enhancing diagnostic accuracy and streamlining clinical workflows. Additionally, the application of natural language processing (NLP) plays a vital role in improving workflow efficiency within medical settings. By interpreting and organizing unstructured clinical data, NLP allows healthcare professionals to access and utilize critical information more effectively, refining diagnostic precision and decreasing the time spent on administrative tasks. As AI, NLP, and advanced analytics continue to evolve, VNA and PACS systems are becoming increasingly integral to optimizing healthcare processes. They contribute not only to improved clinical outcomes but also actively drive the future of precision medicine and integrated care. This evolution positions healthcare to better meet the complexities of patient needs, ultimately leading to enhanced quality of care and better health management across populations.

CHALLENGES: Rising security concerns related to cloud-based image processing and analytics

Cloud computing offers numerous advantages, but its implementation in medical imaging and healthcare data management introduces significant security challenges. The consolidation of sensitive information, including personal health records and diagnostic imaging data, within cloud infrastructures raises critical issues regarding data integrity, availability, privacy, and confidentiality. Cloud service providers (CSPs) are responsible for securing vast amounts of highly sensitive data; however, they must navigate persistent risks such as data breaches, unauthorized access, data theft, and potential service downtime. Consequently, many healthcare organizations are cautious about migrating confidential medical data to the cloud, primarily due to concerns about relinquishing direct control over their information security. Outsourcing data to third-party cloud data centers means that healthcare providers depend on CSP’s security protocols and infrastructure. While CSPs employ various protective measures—ranging from firewalls and encryption to advanced virtualization technologies—these solutions do not ensure foolproof protection against sophisticated cyber threats or inadvertent human errors. Therefore, a careful assessment of the risk-benefit balance is essential for healthcare entities considering cloud adoption.

Global Vendor Neutral Archive (VNA) & PACS Market Ecosystem Analysis

The VNA & PACS market is highly competitive and involves a wide range of intermediaries. Stakeholders in the medical imaging sector operate within a rapidly evolving landscape, significantly influenced by technological advancements and changing healthcare priorities. Key players include VNA and PACS vendors, which range from large corporations to niche specialists, all dedicated to providing cutting-edge solutions for managing and storing imaging data. These vendors are required to navigate complex regulatory frameworks established by agencies such as the FDA, EMA, and Health Canada. These regulations impose strict compliance demands concerning data security, interoperability standards, and patient privacy protections. Moreover, governmental organizations such as the Department of Health and Human Services (HHS) and the National Health Service (NHS) play a critical role in shaping market dynamics through strategic policy-making, funding programs, and regulatory oversight. End users—including hospitals & clinics, ambulatory surgery centers, and diagnostic centers—drive the adoption of VNA and PACS technologies, seeking to enhance workflow efficiency, improve diagnostic precision, and elevate patient care outcomes.

Vendor Neutral Archive (VNA) & PACS Market Ecosystem
 

The VNA segment held the largest market share, by product type, in 2024.

In 2024, the VNA segment held the largest share of the VNA & PACS market due to its capability to provide a centralized repository for storing medical images and related metadata in a standardized format, independent of specific imaging modalities or vendors. VNA enables efficient interoperability for data exchange across diverse systems and healthcare facilities, thereby enhancing collaboration and care coordination among providers. The VNA landscape can be delineated into three categories: departmental, multi-department, and multi-site VNA, each tailored to address the specific requirements of various levels within healthcare organizations. These solutions are essential for handling substantial volumes of imaging data, ensuring that medical images are readily accessible across multiple departments, locations, and systems; this access not only streamlines operational workflows but also optimizes patient care delivery. As the healthcare sector increasingly adopts value-based care models, the significance of comprehensive data management solutions, such as VNA, has escalated. Furthermore, VNA empowers healthcare organizations to leverage medical imaging data for initiatives related to population health management, predictive analytics, and personalized medicine. This strategic positioning has established VNA solutions as pivotal contributors to the evolving landscape of medical imaging and healthcare informatics.

By deployment model, the cloud-based deployment segment is projected to have the highest CAGR during the forecast period.

The VNA & PACS market is segmented by deployment into cloud-based, on-premises, and hybrid deployment. The cloud-based segment is poised for robust growth throughout the forecast period, driven by a multitude of advantageous factors. Cloud-based VNA and PACS solutions eliminate the necessity for substantial investments in on-premises infrastructure, allowing healthcare organizations to leverage scalable storage and computing resources that can be dynamically configured according to fluctuating demand. This adaptability is particularly critical as healthcare entities grapple with the surging volumes of medical imaging data generated from diagnostic modalities such as X-rays, MRIs, and CT scans.

Cloud service providers (CSPs) employ comprehensive security measures—including encryption, stringent access controls, and periodic security audits—to ensure the integrity and confidentiality of patient data. These protocols are essential for meeting regulatory compliance standards such as HIPAA and GDPR, mitigating the risks associated with potential data breaches, which are a major concern for healthcare organizations managing sensitive medical information. In addition, the cost-efficiency of cloud deployment models presents a compelling incentive for organizations aiming to curtail capital expenditures on physical infrastructure while capitalizing on the inherent flexibility of cloud storage solutions. The benefits of remote access and real-time monitoring afforded by cloud-based systems facilitate enhanced collaboration among healthcare professionals, enabling seamless access to imaging data across geographically dispersed locations while ensuring the health and security of the data remain intact.

North America accounted for the largest share of the VNA & PACS market in 2024.

In 2024, North America holds the predominant share of the VNA & PACS market. The region is witnessing a rapid expansion in cloud-based VNA and PACS solutions, driven by a significant shift towards digital health and an increasing demand for scalable and flexible storage architectures. Healthcare providers across the US and Canada are increasingly integrating cloud-based systems to efficiently manage the escalating volumes of medical imaging data, thereby facilitating improved collaboration and expedited access to diagnostic images across distributed healthcare environments. This trend is also influenced by the regulatory landscape, particularly HIPAA compliance requirements, and the broader shift towards value-based healthcare models. Cloud-based architecture offers a cost-effective alternative to traditional on-premises solutions, while also incorporating robust security protocols such as encryption and granular access controls to safeguard sensitive patient information.

LARGEST MARKET SIZE IN 2024
US: FASTEST-GROWING MARKET IN REGION
Vendor Neutral Archive (VNA) & PACS Market Region

Recent Developments of Vendor Neutral Archive (VNA) & PACS Market

  • In April 2025, Siemens Healthineers (Germany) and Tower Health (US) unveiled a 10-year value partnership to upgrade imaging systems and digital tools and enhance diagnostic capabilities.
  • In March 2025, GE Healthcare (US) launched the Genesis Cloud Suite, an enterprise imaging SaaS portfolio offering edge, storage, VNA, and data migration solutions to improve workflow efficiency, precision, and IT resource optimization for healthcare providers.
  • In March 2025, FUJIFILM Healthcare Americas (US) partnered with AWS (US) to enhance digital pathology and cloud integration to streamline data lifecycle management and optimize storage of large pathology files within Fujifilm’s Synapse Pathology platform.
  • In November 2024, Canon Medical Systems Corporation (Japan) partnered with Penn Medicine to advance photon-counting CT (PCCT) technology, following the installation of Canon's fourth global PCCT system at the Hospital of the University of Pennsylvania, aiming to enhance diagnostic capabilities through clinical feedback.

Key Market Players

Want to explore hidden markets that can drive new revenue in Vendor Neutral Archive (VNA) & PACS Market?

Scope of the Report

Report Metric Details
Market size available for years 2023-2030
Base Year Considered 2024
Forecast period 2025-2030
Forecast units Million/Billion (USD)
Segments covered Product Type, Modality, Deployment, Vendor Type, Application, End User, and Region
Geographies covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Frequently Asked Questions(FAQ)

Which are the top industry players in the global Vendor Neutral Archive (VNA) & PACS market?

Prominent players in the VNA & PACS market include Hyland Software, Inc. (US), Agfa-Gevaert Group (Belgium), Intelerad Medical Systems Inc. (Canada), Canon Medical Systems Corporation (Japan), FUJIFILM Holdings Corporation (Japan), GE Healthcare (US), Merative (US), Sectra AB (Sweden), Siemens Healthcare Limited (Germany), BridgeHead Software Ltd. (UK), Canopy Partners. (US), Novarad Corporation (US), POSTDICOM (Netherlands), AdvaHealth Solutions Pte Ltd. (Singapore), CrelioHealth (India), Medicasoft (US), Esaote SPA (Italy), PaxeraHealth (US), VISUS Health IT GmbH (Germany), ASPYRA, LLC (US), Dedalus S.p.A. (Italy), SoftTeam Solutions Pvt. Ltd. (India), ARO Systems (Australia), Central Data Networks (Australia), and ONEPACS (US).

Which products & services have been included in the Vendor Neutral Archive (VNA) & PACS market report?

This report contains the following Vendor Neutral Archive (VNA) & PACS products

  • VNA
    • Department VNA
    • Multi-department VNA
    • Multi-site VNA
  • PACS
    • Department PACS
    • Multi-department PACS
    • Multi-site PACS

 

Which geographical region dominates in the global VNA & PACS market?

The VNA & PACS market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America holds the largest share, and the Asia Pacific registers the highest growth rate in the VNA & PACS market.

Which end-user segments have been included in the VNA & PACS market report?

The report contains the following application segments:\

  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Diagnostic Centers
  • Other End Users

 

What is the total CAGR expected to be recorded for the VNA & PACS market from 2025 to 2030?

The CAGR is expected to record a CAGR of 9.2% from 2025 to 2030

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Vendor Neutral Archive (VNA) & PACS Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
1
RESEARCH METHODOLOGY
45
EXECUTIVE SUMMARY
68
PREMIUM INSIGHTS
92
MARKET OVERVIEW
115
  • 5.1 MARKET DYNAMICS
    DRIVERS
    RESTRAINTS
    OPPORTUNITIES
    CHALLENGES
  • 5.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.3 INDUSTRY TRENDS
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - AI AND ML
    - BLOCKCHAIN TECHNOLOGY
    ADJACENT TECHNOLOGIES
    - DATA ANALYTICS AND BUSINESS INTELLIGENCE TOOLS
    - INTERNET OF THINGS
  • 5.7 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY ANALYSIS
    - North America
    - Europe
    - Asia Pacific
  • 5.8 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT TYPE
    AVERAGE SELLING PRICE TREND, BY REGION
  • 5.9 PORTER’S FIVE FORCES ANALYSIS
  • 5.10 PATENT ANALYSIS
  • 5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.12 END USER ANALYSIS
    UNMET NEEDS
    END USER EXPECTATIONS
  • 5.13 KEY CONFERENCES & EVENTS IN 2025-2026
  • 5.14 CASE STUDY ANALYSIS
  • 5.15 VENDOR NEUTRAL ARCHIVE (VNA) & PACS INVESTMENT AND FUNDING SCENARIO
  • 5.16 VENDOR NEUTRAL ARCHIVE (VNA) & PACS BUSINESS MODELS
VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT YPE
145
  • 6.1 INTRODUCTION
  • 6.2 VNA
    DEPARTMENT VNA
    MULTI-DEPARTMENT VNA
    MULTI-SITE VNA
  • 6.3 PACS
    DEPARTMENT PACS
    MULTI-DEPARTMENT PACS
    MULTI-SITE PACS
VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY
188
  • 7.1 INTRODUCTION
  • 7.2 CT
  • 7.3 MAMMOGRAPHY
  • 7.4 MRI
  • 7.5 ULTRASOUND
  • 7.6 X-RAYS
  • 7.7 PET
VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL
207
  • 8.1 INTRODUCTION
  • 8.2 ON-PREMISE MODEL
  • 8.3 CLOUD-BASED MODEL
  • 8.4 HYBRID MODEL
VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE
245
  • 9.1 INTRODUCTION
  • 9.2 INDEPENDENT VENDOR
  • 9.3 THIRD-PARTY VENDOR
VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION
257
  • 10.1 INTRODUCTION
  • 10.2 CARDIOLOGY
  • 10.3 ORTHOPEDIC
  • 10.4 ONCOLOGY
  • 10.5 NEUROLOGY
  • 10.6 OBSTETRICS AND GYNECOLOGY
  • 10.7 OTHER (DENTAL, RESPIRATORY, UROLOGY AND NEPHROLOGY)
VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER
272
  • 11.1 INTRODUCTION
  • 11.2 HOSPITALS & CLINICS
  • 11.3 DIAGNOSTICS CENTERS
  • 11.4 AMBULATORY SURGICAL CENTERS
  • 11.5 OTHERS (ACADEMIC & RESEARCH INSTITUTES)
VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION
288
  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    US
    CANADA
  • 12.3 EUROPE
    GERMANY
    FRANCE
    UK
    ITALY
    SPAIN
    REST OF EUROPE
  • 12.4 ASIA PACIFIC
    CHINA
    JAPAN
    INDIA
    REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    BRAZIL
    MEXICO
    REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST AND AFRICA
    GCC COUNTRIES
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
301
  • 13.1 OVERVIEW
  • 13.2 STRATEGIES ADOPTED BY KEY PLAYERS
  • 13.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
  • 13.4 MARKET SHARE ANALYSIS
  • 13.5 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • 13.6 VALUATION AND FINANCIAL METRICS OF KEY VENDOR NEUTRAL ARCHIVE (VAN) & PACS VENDORS
  • 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT, KEY PLAYERS, 2024
    - COMPANY FOOTPRINT
    - REGION FOOTPRINT
    - PRODUCT TYPE FOOTPRINT
    - DEPLOYMENT FOOTPRINT
    - END USER FOOTPRINT
  • 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    - DETAILED LIST OF STARTUPS/SMES
    - COMPETITIVE BEMCHMARKING OF KEY STARTUPS/SMES
  • 13.9 COMPETITIVE SCENARIO AND TRENDS
    PRODUCT LAUNCHES
    DEALS
    OTHERS
COMPANY PROFILES
323
  • 14.1 KEY PLAYERS
    HYLAND SOFTWARE, INC.
    AGFA-GEVAERT GROUP.
    INTELERAD MEDICAL SYSTEMS INC
    CANON MEDICAL SYSTEMS CORPORATION
    FUJIFILM HOLDINGS CORPORATION
    GE HEALTHCARE TECHNOLOGIES INC.
    MERATIVE
    SECTRA AB
    SIEMENS HEALTHCARE LIMITED
    BRIDGEHEAD SOFTWARE LTD.
    CANOPY PARTNERS.
    NOVARAD CORPORATION.
    POSTDICOM
    CRELIOHEALTH
    MEDICASOFT.
    ESAOTE SPA
    PAXERAHEALTH
  • 14.2 VISUS HEALTH IT GMBH
    ASPYRA, LLC
VISUS HEALTH IT GMBH
334
ADVAHEALTH SOLUTIONS PTE LTD
  • 15.1 OTHER PLAYERS
    DEDALUS S.P.A.
    SOFTTEAM SOLUTIONS PVT LTD.
    ARO SYSTEMS
    CENTRAL DATA NETWORKS
    ONEPACS
APPENDIX
345
  • 16.1 DISCUSSION GUIDE
  • 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 16.3 AVAILABLE CUSTOMIZATIONS
  • 16.4 RELATED REPORTS
  • 16.5 AUTHOR DETAILS

 

The study involved five major activities to estimate the current size of the vendor-neutral archive (VNA) & picture archiving and communication systems (PACS) market—exhaustive secondary research collected information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

This research study used secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Business, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for companies providing VNA & PACS solutions is assessed using secondary data from paid and free sources; this involves analyzing the product portfolios of major players and evaluating these companies based on their performance and quality. Various resources were utilized in the secondary research process to gather information for this study. The sources include annual reports, press releases, investor presentations, white papers, academic journals, certified publications, articles by recognized authors, directories, and databases.

The secondary research process involved referring to various secondary sources to identify and collect information related to the study. These sources included annual reports, press releases, investor presentations of VNA and PACS vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information and assess prospects.

Primary research was conducted to identify segmentation types, industry trends, key players, and key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies adopted by key players.

After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis. Additionally, primary research was conducted to identify different types of market segmentation, analyze industry trends, evaluate the competitive landscape of VNA and PACS solutions offered by various players, and understand key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies employed by key market participants.

In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

Breakdown of Primary Respondents:

Vendor Neutral Archive (VNA) & PACS Market

Note 1: Others include sales, marketing, and product managers.

Note 2: Tiers are defined based on a company’s total revenue, as of 2022: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through the bottom-up approach (revenue share analysis) and top-down approach (assessment of utilization/adoption/penetration trends, by product type, modality, deployment, vendor type, application, end user, and region).

Vendor Neutral Archive (VNA) & PACS Market

Data Triangulation

After arriving at the overall market size, the market size estimation process splits the market into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from the demand and supply sides in the VNA & PACS market.

Market Definition

The VNA & PACS market encompasses advanced medical imaging technologies that deliver cost-effective storage solutions and streamlined access to multimodal imaging data. These systems are pivotal within the healthcare IT ecosystem, enabling efficient digitization, storage, retrieval, and sharing of medical imaging data across diverse platforms. By ensuring interoperability and secure management of imaging data, VNA and PACS facilitate improved clinical workflows and enhance collaboration among healthcare professionals.

Stakeholders

  • VNA & PACS  Vendors
  • Government Bodies
  • Healthcare Service Providers
  • Clinical/Physician Centers
  • Healthcare Professionals
  • Health IT service Providers
  • Healthcare Associations/Institutes
  • Ambulatory Care Centers
  • Venture Capitalists
  • Distributors And Resellers
  • Maintenance And Support Service Providers
  • Integration Service Providers
  • Healthcare Payers
  • Advocacy Groups
  • Data Security and Privacy Experts
  • Investors And Financial Institutions
  • Industry Associations and Trade Groups

Report Objectives

  • To define, describe, and forecast the global VNA & PACS market by product type, modality, deployment, vendor type, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall VNA & PACS market
  • To assess the VNA & PACS market with regard to Porter’s Five Forces, regulatory landscape, value chain, ecosystem map, patent protection, and key stakeholder & buying criteria
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the VNA & PACS market with respect to five main regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • To profile the key players in the VNA & PACS market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as agreements, partnerships, acquisitions; expansions; product launches and enhancements; and R&D activities in the VNA & PACS market.

 

Previous Versions of this Report

Vendor Neutral Archive (VNA) & PACS Market by Product Type (Department, Multi-department, Multi-Site), Modality (CT, MRI, X-rays, Ultrasound, Mammo, PET), Application (Cardio, Onco, Neuro), End User (Hospital, ASC, Diag center) & Region - Global Forecast to 2029

Report Code HIT 2128
Published in May, 2024, By MarketsandMarkets™

Vendor Neutral Archive ( VNA ) & PACS Market - VNA [On-premise Software, Hybrid & Cloud, Multi-Department & Multi-Site VNA] & Picture Archiving and Communication System [Enterprise, Cardiology & Radiology] - Global Forecast to 2018

Report Code HIT 2128
Published in Oct, 2013, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Vendor Neutral Archive (VNA) & PACS Market

DMCA.com Protection Status